Tectonic Therapeutic (TECX) Other Non Operating Income (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Other Non Operating Income of -$113000.0 for Q1 2026, down 253.12% year-over-year from $73795.9 in Q1 2025, and down 102.67% quarter-over-quarter from $4.2 million in Q4 2025.
Tectonic Therapeutic (TECX) Other Non Operating Income (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Other Non Operating Income for 9 consecutive years, with -$113000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income fell 253.12% year-over-year to -$113000.0; the TTM figure through Mar 2026 stood at $4.0 million (up 3010.79% YoY), while the FY2025 annual figure was $4.1 million, up 907.63% from the prior year.
- Other Non Operating Income eased to -$113000.0 in Q1 2026 per TECX's latest filing, from $4.2 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $4.2 million in Q4 2025 and bottomed at -$403000.0 in Q1 2024.
- Historically, Other Non Operating Income has averaged $236312.5 across 5 years, with a median of -$19500.0 in 2023.
- Annual changes were most pronounced in 2024 — Other Non Operating Income tumbled 2786.67% — and 2025, when it soared 4561.05%.
- Tectonic Therapeutic's Other Non Operating Income stood at -$95000.0 in 2022, then jumped by 527.37% to $406000.0 in 2023, then slumped by 123.4% to -$95000.0 in 2024, then jumped by 4561.05% to $4.2 million in 2025, then slumped by 102.67% to -$113000.0 in 2026.
- Business Quant data shows TECX's Other Non Operating Income at -$113000.0 in Q1 2026, $4.2 million in Q4 2025, and -$31000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5,000.00 |
| Mar 31, 2026 | -113,000.00 |
| Dec 31, 2025 | 4.24 Mn |
| Sep 30, 2025 | -31,000.00 |
| Jun 30, 2025 | -48,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Dec 31, 2024 | -95,000.00 |
| Sep 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -403,000.00 |
| Dec 31, 2023 | 406,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -8,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Sep 30, 2022 | -95,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | -45,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | -21,000.00 |
| Sep 30, 2020 | -74,000.00 |